These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36606729)

  • 1. Viral hepatitis elimination challenges in low- and middle-income countries-Uzbekistan Hepatitis Elimination Program (UHEP).
    Musabaev E; Estes C; Sadirova S; Bakieva S; Brigida K; Dunn R; Kottilil S; Mathur P; Abutaleb A; Razavi-Shearer K; Anstiss T; Yusupaliev B; Razavi H
    Liver Int; 2023 Apr; 43(4):773-784. PubMed ID: 36606729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020.
    Dunn R; Musabaev E; Razavi H; Sadirova S; Bakieva S; Razavi-Shearer K; Brigida K; Kamili S; Averhoff F; Nasrullah M
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(34):1161-1165. PubMed ID: 32853186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Training the healthcare workforce to support task-shifting and viral hepatitis elimination: a global review of English language online trainings and in-person workshops for management of hepatitis B and C infection.
    Corcorran MA; Scott JD; Naveira M; Easterbrook P
    BMC Health Serv Res; 2023 Aug; 23(1):849. PubMed ID: 37568106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and facilitators to viral hepatitis testing in Uzbekistan: scoping qualitative study among key stakeholders, healthcare workers, and the general population.
    Mazhnaya A; Geurts B; Brigida K; Bakieva S; Sadirova S; Witzigmann A; Musabaev E; Brandl M; Weishaar H; Dudareva S; Bcheraoui CE
    BMC Public Health; 2024 Jun; 24(1):1482. PubMed ID: 38831285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.
    Ishizaki A; Bouscaillou J; Luhmann N; Liu S; Chua R; Walsh N; Hess S; Ivanova E; Roberts T; Easterbrook P
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):696. PubMed ID: 29143609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
    Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
    Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Coronavirus Disease 2019 Pandemic on Viral Hepatitis Elimination: What Is the Price?
    Sowah L; Chiou C
    AIDS Res Hum Retroviruses; 2021 Aug; 37(8):585-588. PubMed ID: 33913731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income.
    Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Chhatwal J; Ball A
    Value Health; 2020 Dec; 23(12):1552-1560. PubMed ID: 33248510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan.
    Ruzibakiev R; Kato H; Ueda R; Yuldasheva N; Hegay T; Avazova D; Kurbanov F; Zalalieva M; Tuichiev L; Achundjanov B; Mizokami M
    Intervirology; 2001; 44(6):327-32. PubMed ID: 11805437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The medical impact of hepatitis D virus infection in Uzbekistan.
    Khodjaeva M; Ibadullaeva N; Khikmatullaeva A; Joldasova E; Ismoilov U; Colombo M; Caviglia GP; Rizzetto M; Musabaev E
    Liver Int; 2019 Nov; 39(11):2077-2081. PubMed ID: 31505080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaps in Viral Hepatitis Awareness in the United States in a Population-based Study.
    Zhou K; Terrault NA
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):188-195.e4. PubMed ID: 31173892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.
    Bottero J; Brouard C; Roudot-Thoraval F; Deuffic-Burban S; Hofliger P; Abergel A; Volant J; Dhumeaux D; Yazdanpanah Y;
    Liver Int; 2016 Oct; 36(10):1442-9. PubMed ID: 27043826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the first, second and third waves of covid-19 on hepatitis B and C testing in Ontario, Canada.
    Mandel E; Peci A; Cronin K; Capraru CI; Shah H; Janssen HLA; Tran V; Biondi MJ; Feld JJ
    J Viral Hepat; 2022 Mar; 29(3):205-208. PubMed ID: 34820967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of Refugees' Inclusion in National Viral Hepatitis B and Hepatitis C Screening Campaign in Mahama Refugee Camp, Rwanda.
    Nyirahabihirwe F; Kamali I; Barnhart DA; Gakuru JP; Musafiri T; Rwamuhinda DD; Mutabazi P; Mukayirabuka S; Makuza JD; Kassim N; Mubiligi JM; Ndahimana JD; Kateera F
    Glob Health Sci Pract; 2022 Apr; 10(2):. PubMed ID: 35487545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBV and HCV infections in heart transplant recipients.
    Fagiuoli S; Minniti F; Pevere S; Farinati F; Burra P; Livi U; Naccarato R; Chiaramonte M
    J Heart Lung Transplant; 2001 Jul; 20(7):718-24. PubMed ID: 11448796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting.
    Le LV; Blach S; Rewari B; Chan P; Fuqiang C; Ishikawa N; Sharma M; Mangadan-Konath N; Razavi H; Low-Beer D; Razavi-Shearer D
    Liver Int; 2022 Aug; 42(9):1930-1934. PubMed ID: 34894047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of sustained reductions in the relative risk of acute hepatitis B and C virus infections, and the increasing burden of hepatitis a virus infection in Egypt: comparison of sentinel acute viral hepatitis surveillance results, 2001-17.
    Talaat M; Afifi S; Reaves EJ; Abu Elsood H; El-Gohary A; Refaey S; Hammad R; Abdel Fadeel M; Kandeel A
    BMC Infect Dis; 2019 Feb; 19(1):159. PubMed ID: 30764780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study.
    Kamali I; Barnhart DA; Ndahimana JD; Noor K; Mumporeze J; Nyirahabihirwe F; Gakuru JP; Musafiri T; Urusaro S; Makuza JD; Serumondo J; Rwamuhinda DD; Nkundibiza M; Kateera F; Nshogoza GR; Mubiligi JM
    PLoS One; 2021; 16(10):e0257917. PubMed ID: 34634039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research gaps in viral hepatitis.
    Boyd A; Duchesne L; Lacombe K
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25054. PubMed ID: 29633564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.